Depot-related gene expression in human subcutaneous and omental adipocytes

Diabetes

Volumn 47, Issue 9, 1998, Pages 1384-1391

  Montague, Carl T ^a,b   Prins, Johannes B ^a   Sanders, Louise ^a   Zhang, Junlong ^a   Sewter, Ciaran P ^a   Digby, Janet ^a   Byrne, Christopher D ^a   O'Rahilly, Stephen ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTE; ARTICLE; BODY FAT; DIABETES MELLITUS; HUMAN; HUMAN CELL; INSULIN SENSITIVITY; OBESITY; PRIORITY JOURNAL; SUBCUTANEOUS TISSUE;

EID: 0031678588     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.9.1384     Document Type: Article

References (49)

1. Vague J: La differenciation sexuelle, facteur determinant des formes de l'obesite. Press Med 55:339-340, 1947
2. Krotkiewski M, Bjorntorp P, Sjostrom L, Smith U: Impact of obesity on metabolism in men and women: importance of regional adipose tissue distribution. J Clin Invest 72:1150-1162, 1983
3. Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjostrom L: Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J 289:1257-1261, 1984
4. Kannel WB, Cupples LA, Ramaswami R, Stokes J, Kreger BE, Higgins M: Regional obesity and risk of cardiovascular disease; the Framingham study. J Clin Epidemiol 44:183-190, 1991
5. Kissebah AH, Vydelingum N, Murray M, Evans DJ, Hartz AJ, Kalkhoff RK, Adams PW: Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 54:254-260, 1982
6. Gillum RF: The association of body fat distribution with hypertension, hypertensive heart disease, coronary heart disease, diabetes and cardiovascular risk factors in men and women aged 18-79 years. J Chron Dis 40:421-428, 1987
7. Peiris AN, Hennes MI, Evans DJ, Wilson CR, Lee MB, Kissebah AH: Relationship of anthropometric measurements of body fat distribution to metabolic profile in premenopausal women. Acta Med Scand (Suppl.) 723:179-188, 1988
8. Fujioka S, Matsuzawa Y, Tokunaga K, Kawamoto T, Kobatake T, Keno Y, Kotani K, Yoshida S, Tarui S: Improvement of glucose and lipid metabolism associated with selective reduction of intra-abdominal visceral fat in premenopausal women with visceral fat obesity. Int J Obesity 15:853-859, 1990
9. Kissebah AH, Krakower GR: Regional adiposity and morbidity. Physiological Rev 74:761-811, 1994
10. Byrne CD, Brindle NPJ, Wang TWM, Hales CN: Interaction of non-esterified fatty acid and insulin in control of triacylglycerol secretion by Hep G2 cells. Biochem J 280:99-104, 1991
11. Martin ML, Jensen MD: Effects of body fat distribution on regional lipolysis in obesity. J Clin Invest 88:609-613, 1991
12. Mårin P, Lönn L, Andersson B, Odén B, Olbe L, Bengtsson B-A, Björntorp P: Assimilation of triglycerides in subcutaneous and intraabdominal adipose tissue in Vivo in men: effects of testosterone. J Clin Endocrinol Metab 81:1018-1022, 1996
13. Östmart J, Arner P, Engfeldt P, Kager L: Regional differences in the control of lipolysis in human adipose tissue. Metabolism 28:1198-1205, 1979
14. Wahrenberg H, Lönnqvist F, Arner P: Mechanisms underlying regional differences in lipolysis in human adipose tissue. J Clin Invest 84:458-467, 1989
15. Bolinder J, Kager L, Ostman J, Arner P: Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis. Diabetes 32:117-123, 1983
16. Richelsen B, Pedersen SB, Moller-Pedersen T, Bak JF: Regional differences in triglyceride breakdown in human adipose tissue: effects of catecholamines, insulin and prostaglandin e2. Metabolism 40:990-996, 1991
17. Rebuffé-Scrive M, Bronnegard M, Nilsson A, Eldh J, Gustafsson J-A, Björntorp P: Steroid hormone receptors in human adipose tissues. J Clin Endocrinol Metab 71:1215-1219, 1990
18. Fried SK, Russell CD, Grauso NL, Brolin RE: Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men. J Clin Invest 92:2191-2198, 1993
19. Björntorp P: The android women: a risky condition. J Intern Med 239:105-110, 1996
20. Moghetti P, Tosi F, Castello R, Magnani CM, Negri C, Brun E, Furlani L, Caputo M, Muggeo M: The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women. J Clin Endocrinol Metab 81:952-960, 1996
21. Bouchard C: Genetic factors in the regulation of adipose tissue distribution. Acta Med Scand Suppl 723:135-141, 1992
22. Stunkard AJ, Sørenson TIA, Hanis C, Teasdale TW, Chakraborty R, Schull WJ, Schulsinger F: An adoption study of human obesity. N Engl J Med 314:193-198, 1986
23. Montague CT, Prins JB, Sanders L, Digby JE, O'Rahilly S: Depot- and sex-specific differences in human leptin mRNA expression. Diabetes 46:342-347, 1997
24. Lefebvre A-M, Laville M, Vega N, Riou JP van Gaal L, Auwerx J, Vidal H: Depot-specific differences in adipose tissue gene expression in lean and obese subjects. Diabetes 47:98-103, 1998
25. Zhang J, Desai M, Ozanne SE, Doherty C, Hales CN, Byrne CD: Two variants of quantitative reverse transcriptase PCR used to show differential expression of α-,β- and γ- fibrinogen genes in rat liver lobes. Biochem J 321:769-775, 1997
26. Zhang J, Byrne CD: A novel highly reproducible quantitative competitive RT PCR system. J Mol Biol 274:338-352, 1997
27. Raeymaekers L: Quantitative PCR: theoretical considerations with practical implications. Anal Biochem 214:582-585, 1993
28. Liang P, Pardee AB: Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257:967-971, 1992
29. Colantuoni V, Romano V, Bensi G, Santoro C, Costanzo F, Raugei G, Cortese R: Cloning and sequencing of a full length cDNA coding for human retinol-binding protein. Nucl Acids Res 11:7769-7776, 1983
30. Makover A, Soprano DR, Wyatt ML, Goodman DS: Localization of retinol-binding protein messenger RNA in the rat kidney and in perinephric fat tissue. J Lipid Res 30:171-180, 1989
31. Rothe M, M-G Pan, Henzel WJ, Ayres TM, Goeddel DV: The TNF-R2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83:1243-1252, 1995
32. Rothe M, Wong SC, Henzel WJ, Goeddel DV: A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78:681-692, 1994
33. Rydén M, Imamura T, Jörnvall H, Belluardo N, Neveu I, Trupp M, Okadome T, Dijke PT, Ibáñez CF: A novel type I receptor serine-threonine kinase predominately expressed in the adult central nervous system. J Biol Chem 271:30603-30609, 1996
34. Prins JB, Niesler CU, Winterford CM, Bright NA, Siddle K, O'Rahilly S, Walker NI, Cameron DP: TNF-α induces apoptosis of human adipose cells. Diabetes 46:1939-1944, 1997
35. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumour necrosis factor-a: direct role in obesity-linked insulin resistance. Science 259:87-91, 1993
36. Kern PA, M Saghizadeh, Ong JM, Bosch RJ, Deem R, Simsolo RB: The expression of tumour necrosis factor in human adipose tissue: regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 95:2111-2119, 1995
37. Dandona P, Weinstock R, Love J, Thusu K, Aljada A, Wadden T: Elevated tumor necrosis factor α in sera of obese patients: fall with weight loss (Abstract). Diabetes 45:173A, 1996
38. Kirchgessner TG, Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS: Tumor necrosis factor-α contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest 100:2777-2782, 1997
39. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM: Increased adipose tissue expression of tumor necrosis factor-a in human obesity and insulin resistance. J Clin Invest 95:2409-2415, 1995
40. Song HY, Régnier CH, Kirschning CJ, Goeddel DV, Rothe M: Tumor necrosis factor (TNF-)-mediated kinase cascades: bifurcation of nuclear factor-κB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF- receptor-associated factor 2. Proc Natl Acad Sci U S A 94:9792-9796, 1997
41. Chu Z-L, McKinsey TA, Liu L, Gentry JJ, Malim MH, Ballard DW: Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control. Proc Natl Acad Sci U S A 94:10057-10062, 1997
42. Bertioli DJ, Schlichter UHA, Adams MJ, Burrows PR, Steinbiss H-H, Antoniw JF: An analysis of differential display shows a strong bias towards high copy number mRNAs. Nucl Acids Res 23:4520-4523, 1995
43. Adams M, Montague CT, Prins JB, Holder JC, Smith SA, Sanders L, Sewter CP, Digby JE, Lazar MA, Chatterjee VKK, O'Rahilly S: Activators of PPAR-γ have depot-specific effects on human pre-adipocyte differentiation. J Clin Invest 100:3149-3153, 1997
44. Yanase T, Yashiro T, Takitani K, Kato S, Taniguchi S, Takayanagi R, Nawata H: Differential expression of PPAR-γ1 and γ2 isoforms in human adipose tissue. Biochem Biophysic Res Comm 233:320-324, 1997
45. Vidal-Puig AJ, Considine RV, Jimenez-Liñan M, Werman A, Pories WJ, Caro JF: Peroxisome proliferator-activated receptor gene expression in human tissues: effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest 99:2416-2422, 1997
46. Auboeuf D, Rieusset J, Fajas L, Vallier P, Frering V, Riou JP, Staels B, Auwerx J, Laville M, Vidal H: Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-α in humans. Diabetes 46:1319-1327, 1997
47. Xing H, Northrop JP, Grove JR, Kilpatrick KE, Su J-L, Ringold GM: TNF-α-mediated inhibition and reversal of adipocyte differentiation is accompanied by suppressed expression of PPAR-γ without effects on Pref-1 expression. Endocrinology 138:2776-2783, 1997
48. Kallen CB, Lazar MA: Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes. Proc Natl Acad Sci U S A 93:5793-5796, 1996
49. Zhang B, Grazianno MP, Doebber TW, Leibowitz MD, White-Carrington S, Szalkowski DM, Hey PJ, Wu M, Cullinan CA, Bailey P, Lollman B, Frederich R, Flier JS, Strader CD, Smith RG: Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice. J Biol Chem 271:9455-9459, 1996